Immunovia strengthens its US team through the appointment of Natalie Carfora as Head of Market Access US

LUND, Sweden, May 16, 2022 /PRNewswire/ --Immunovia (Nasdaq Stockholm: IMMNOV) has appointed Natalie Carfora as Head of Market Access of its US subsidiary, Immunovia, Inc. Natalie brings deep expertise to the reimbursement process from prior market access roles at Scipher Medicine and Myriad Genetics.